about
[Transcriptome expression analyses of pulmonary renal cell carcinoma metastases]SCRIB expression is deregulated in human prostate cancer, and its deficiency in mice promotes prostate neoplasiaQuality aspects of TMA analysis.Open and robot-assisted radical retropubic prostatectomy in men receiving ongoing low-dose aspirin medication: revisiting an old paradigm?Oncological long-term outcome of 4772 patients with prostate cancer undergoing radical prostatectomy: does the anaesthetic technique matter?External validation of the CAPRA-S score to predict biochemical recurrence, metastasis and mortality after radical prostatectomy in a European cohort.ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapy.Impact of surgeon-defined capsular incision during radical prostatectomy on biochemical recurrence rates.19q13 amplification is associated with high grade and stage in pancreatic cancer.Additional elastography-targeted biopsy improves the agreement between biopsy Gleason grade and Gleason grade at radical prostatectomy.Concurrent deletion of 16q23 and PTEN is an independent prognostic feature in prostate cancer.The zinc-finger transcription factor SALL4 is frequently expressed in human cancers: association with clinical outcome in squamous cell carcinoma but not in adenocarcinoma of the esophagus.Oncological outcome after radical prostatectomy: Marital status does not make a difference.Loss of CDKN1B/p27Kip1 expression is associated with ERG fusion-negative prostate cancer, but is unrelated to patient prognosis.High c-MET expression is frequent but not associated with early PSA recurrence in prostate cancerEpidermal growth factor receptor protein expression and genomic alterations in renal cell carcinoma.Prognostic value of alpha-methyl CoA racemase (AMACR) expression in renal cell carcinoma.HPV status in patients with head and neck of carcinoma of unknown primary site: HPV, tobacco smoking, and outcome.No impact of blood transfusion on oncological outcome after radical prostatectomy in patients with prostate cancer.High tissue density of FOXP3+ T cells is associated with clinical outcome in prostate cancer.Overexpression of carbonic anhydrase IX (CAIX) is an independent unfavorable prognostic marker in endometrioid ovarian cancer.Risk assessment of metastatic recurrence in patients with prostate cancer by using the Cancer of the Prostate Risk Assessment score: results from 2937 European patients.Expression of insulin-like growth factor II mRNA-binding protein 3 in squamous cell carcinomas of the head and neck.Role of TP53 mutations in vulvar carcinomas.Intratumoral T but not B lymphocytes are related to clinical outcome in prostate cancer.Safe-R: a novel score, accounting for oncological safe nerve-sparing at radical prostatectomy for localized prostate cancer.Tumor volume in insignificant prostate cancer: increasing threshold gains increasing risk.Does HistoScanning™ predict positive results in prostate biopsy? A retrospective analysis of 1,188 sextants of the prostate.Prognostic utility of the cell cycle progression score generated from biopsy in men treated with prostatectomy.Patterns of TPD52 overexpression in multiple human solid tumor types analyzed by quantitative PCR.Neurovascular structure-adjacent frozen-section examination (NeuroSAFE) increases nerve-sparing frequency and reduces positive surgical margins in open and robot-assisted laparoscopic radical prostatectomy: experience after 11,069 consecutive patienCharacterization of Enterobacter cloacae pneumonia: a single-center retrospective analysis.Nerve-sparing Surgery Technique, Not the Preservation of the Neurovascular Bundles, Leads to Improved Long-term Continence Rates After Radical Prostatectomy.TMPRSS2-ERG fusions are strongly linked to young patient age in low-grade prostate cancer.Functional and oncological outcomes of patients aged <50 years treated with radical prostatectomy for localised prostate cancer in a European population.Survival and overall treatment time after postoperative radio(chemo)therapy in patients with head and neck cancer.Role of cyclin D1 amplification and expression in vulvar carcinomas.Limited prognostic value of preoperative circulating tumor cells for early biochemical recurrence in patients with localized prostate cancer.Differences in Patient Characteristics Among Men Choosing Open or Robot-Assisted Radical Prostatectomy in Contemporary Practice at a European High-Volume Center.True targeting-derived prostate biopsy: HistoScanning™ remained inadequate despite advanced technical efforts.
P50
Q33290318-47C041A3-21EA-4ECD-B138-AE1F7D1D2755Q35572506-FE2F25E5-F73D-4266-9173-F6C8A3D7B096Q37778320-84B433FE-13E2-4712-9E48-7F67D1562FFBQ38152800-F1D50422-39F0-49EE-971B-BF7AC799BAD4Q38194784-03C400C1-56C8-4726-B5AC-2CFE8774DB6BQ39077595-1923B747-12C4-4F6D-9694-61EE3A181F31Q39500478-387CAF44-4D39-476C-A418-CC9CFF8A4347Q39898461-280E2349-C46F-4642-B149-1AC743286541Q40045624-22AC2AFA-303B-497F-9600-A41417043B58Q40415928-D0A75673-F28D-43F3-9160-FBCA33652175Q40903462-ABE022BC-3BBE-4443-8620-D610747AB3B7Q40946558-03C3FA0B-7D77-4CB3-B97F-FF786BA374F3Q41204578-31D1808B-7FD1-4924-B0E0-8CF7E98068C2Q42126151-D60EA910-E9AF-4D3F-ABFD-6031B6E78738Q42414387-422B19BD-E4ED-4044-A1B6-BC51FE73D3BAQ43407740-DDD14360-55EC-45AB-8C8D-6C4049742C03Q43673241-7CC2FCF8-00D7-45C0-9029-760AAED545D0Q43712571-4AF26A16-3589-4B55-909E-4F09075A7566Q43773020-228E724F-8576-4BE7-8FBB-98113ABC3A66Q43811286-AE5C3E46-F2DC-47ED-870F-01530CB4D817Q44620601-39B096EC-DA24-4220-AF99-194AB434145BQ44759241-C9A04961-7210-4332-AB85-D04FAF0E701BQ45783352-A7A1F25E-D469-4A04-B3C6-E3015BEAB3D5Q45825015-42A15B68-CD3B-4352-B079-C977424CBE2FQ46094220-DFFAB792-F3AE-4BA7-9108-3667C33BCEE5Q46333989-B1C73930-EEC7-454F-8564-BF6BB0B162D2Q46334818-3549C0DE-9366-4976-992D-A8949548A0E7Q46656192-A09B62DC-AA65-41AE-B4E3-677F04C6DF69Q48355294-CBE9AE35-508E-441D-BC31-F4BAD3E55F56Q48819624-B8371341-0FDD-4077-AF7B-672F2078C8A3Q50944458-F1070C55-6C21-425B-A3DB-9A8DB9B0B722Q50999707-6C806396-FFD6-402E-9BE2-38C13D1FEA36Q51807703-1168FE99-681B-41FA-8A13-F6EA3E21E404Q51837762-14CC74CD-B2EB-46E4-9D74-5C7052BF3657Q53103057-C856BD3F-E625-45A4-9663-2185D941124CQ53175853-A6411F83-75A9-42A0-80DE-5011DB3A3A97Q53180385-81AC9D8C-C917-4503-BF32-D2E6B7490455Q53200611-014542FB-73E5-4CB9-A754-A42E1B4D0D8FQ53205318-F0AA0955-91C0-4DEC-9F4F-C977EE9DA4D3Q53405748-1917089A-EC58-439D-9D52-4C46A62107EB
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Pierre Tennstedt
@ast
Pierre Tennstedt
@en
Pierre Tennstedt
@es
Pierre Tennstedt
@nl
Pierre Tennstedt
@sl
type
label
Pierre Tennstedt
@ast
Pierre Tennstedt
@en
Pierre Tennstedt
@es
Pierre Tennstedt
@nl
Pierre Tennstedt
@sl
prefLabel
Pierre Tennstedt
@ast
Pierre Tennstedt
@en
Pierre Tennstedt
@es
Pierre Tennstedt
@nl
Pierre Tennstedt
@sl
P214
P106
P21
P214
P31
P496
0000-0001-9237-3442
P735
P7859
viaf-18406110